 | • レポートコード：MR2211MG12710 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：製薬・ヘルスケア |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、月経困難症用NSAIDのグローバル市場規模と予測を記載しています。・月経困難症用NSAIDのグローバル市場：売上、2017年-2022年、2023年-2028年 ・月経困難症用NSAIDのグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 月経困難症用NSAIDのグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「イブプロフェン」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 月経困難症用NSAIDのグローバル主要企業は、IOLCP、Granules Biocause、Strides Shasun、BASF、SI Group、Hisoar、Pfizer Inc、Teva、Mylan、Apotex、Lupin、SANOFI-Aventis、Boehringer-Ingelheim、BEC Chemicals、Shandong Xinhua Pharmaceutical、Hengrui Medicine、Hubei Biocause Heilen Pharmaceutical、Zibo Xinhua-PERRIGO Pharmaceutical、Zhejiang Jiuzhou、Hubei Xundaなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、月経困難症用NSAIDのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の月経困難症用NSAID市場：タイプ別、2017年-2022年、2023年-2028年 世界の月経困難症用NSAID市場：タイプ別市場シェア、2021年 ・イブプロフェン、セレコキシブ、ケトプロフェン、その他 世界の月経困難症用NSAID市場：用途別、2017年-2022年、2023年-2028年 世界の月経困難症用NSAID市場：用途別市場シェア、2021年 ・病院、診療所、薬局、その他 世界の月経困難症用NSAID市場：地域・国別、2017年-2022年、2023年-2028年 世界の月経困難症用NSAID市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における月経困難症用NSAIDのグローバル売上、2017年-2022年 ・主要企業における月経困難症用NSAIDのグローバル売上シェア、2021年 ・主要企業における月経困難症用NSAIDのグローバル販売量、2017年-2022年 ・主要企業における月経困難症用NSAIDのグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 IOLCP、Granules Biocause、Strides Shasun、BASF、SI Group、Hisoar、Pfizer Inc、Teva、Mylan、Apotex、Lupin、SANOFI-Aventis、Boehringer-Ingelheim、BEC Chemicals、Shandong Xinhua Pharmaceutical、Hengrui Medicine、Hubei Biocause Heilen Pharmaceutical、Zibo Xinhua-PERRIGO Pharmaceutical、Zhejiang Jiuzhou、Hubei Xunda ************************************************************* ・調査・分析レポートの概要 月経困難症用NSAID市場の定義 市場セグメント 世界の月経困難症用NSAID市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の月経困難症用NSAID市場規模 世界の月経困難症用NSAID市場規模：2021年 VS 2028年 世界の月経困難症用NSAID市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの月経困難症用NSAIDの売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の月経困難症用NSAID製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：イブプロフェン、セレコキシブ、ケトプロフェン、その他 月経困難症用NSAIDのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、薬局、その他 月経困難症用NSAIDの用途別グローバル売上・予測 ・地域別市場分析 地域別月経困難症用NSAID市場規模 2021年と2028年 地域別月経困難症用NSAID売上・予測 北米市場 - アメリカの月経困難症用NSAID市場規模2017年-2028年 - カナダの月経困難症用NSAID市場規模2017年-2028年 - メキシコの月経困難症用NSAID市場規模2017年-2028年 ヨーロッパ市場 - ドイツの月経困難症用NSAID市場規模2017年-2028年 - フランスの月経困難症用NSAID市場規模2017年-2028年 - イギリスの月経困難症用NSAID市場規模2017年-2028年 - イタリアの月経困難症用NSAID市場規模2017年-2028年 - ロシアの月経困難症用NSAID市場規模2017年-2028年 アジア市場 - 中国の月経困難症用NSAID市場規模2017年-2028年 - 日本の月経困難症用NSAID市場規模2017年-2028年 - 韓国の月経困難症用NSAID市場規模2017年-2028年 - 東南アジアの月経困難症用NSAID市場規模2017年-2028年 - インドの月経困難症用NSAID市場規模2017年-2028年 南米市場 - ブラジルの月経困難症用NSAID市場規模2017年-2028年 - アルゼンチンの月経困難症用NSAID市場規模2017年-2028年 中東・アフリカ市場 - トルコの月経困難症用NSAID市場規模2017年-2028年 - イスラエルの月経困難症用NSAID市場規模2017年-2028年 - サウジアラビアの月経困難症用NSAID市場規模2017年-2028年 - UAEの月経困難症用NSAID市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） IOLCP、Granules Biocause、Strides Shasun、BASF、SI Group、Hisoar、Pfizer Inc、Teva、Mylan、Apotex、Lupin、SANOFI-Aventis、Boehringer-Ingelheim、BEC Chemicals、Shandong Xinhua Pharmaceutical、Hengrui Medicine、Hubei Biocause Heilen Pharmaceutical、Zibo Xinhua-PERRIGO Pharmaceutical、Zhejiang Jiuzhou、Hubei Xunda ... |
Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
This report contains market size and forecasts of NSAIDs for Dysmenorrhea in global, including the following market information:
Global NSAIDs for Dysmenorrhea Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global NSAIDs for Dysmenorrhea Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five NSAIDs for Dysmenorrhea companies in 2021 (%)
The global NSAIDs for Dysmenorrhea market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ibuprofen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Hisoar, Pfizer Inc, Teva and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NSAIDs for Dysmenorrhea manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NSAIDs for Dysmenorrhea Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Type, 2021 (%)
Ibuprofen
Celecoxib
Ketoprofen
Others
Global NSAIDs for Dysmenorrhea Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Other
Global NSAIDs for Dysmenorrhea Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NSAIDs for Dysmenorrhea revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies NSAIDs for Dysmenorrhea revenues share in global market, 2021 (%)
Key companies NSAIDs for Dysmenorrhea sales in global market, 2017-2022 (Estimated), (K Units)
Key companies NSAIDs for Dysmenorrhea sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Pfizer Inc
Teva
Mylan
Apotex
Lupin
SANOFI-Aventis
Boehringer-Ingelheim
BEC Chemicals
Shandong Xinhua Pharmaceutical
Hengrui Medicine
Hubei Biocause Heilen Pharmaceutical
Zibo Xinhua-PERRIGO Pharmaceutical
Zhejiang Jiuzhou
Hubei Xunda
1 Introduction to Research & Analysis Reports
1.1 NSAIDs for Dysmenorrhea Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSAIDs for Dysmenorrhea Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSAIDs for Dysmenorrhea Overall Market Size
2.1 Global NSAIDs for Dysmenorrhea Market Size: 2021 VS 2028
2.2 Global NSAIDs for Dysmenorrhea Revenue, Prospects & Forecasts: 2017-2028
2.3 Global NSAIDs for Dysmenorrhea Sales: 2017-2028
3 Company Landscape
3.1 Top NSAIDs for Dysmenorrhea Players in Global Market
3.2 Top Global NSAIDs for Dysmenorrhea Companies Ranked by Revenue
3.3 Global NSAIDs for Dysmenorrhea Revenue by Companies
3.4 Global NSAIDs for Dysmenorrhea Sales by Companies
3.5 Global NSAIDs for Dysmenorrhea Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 NSAIDs for Dysmenorrhea Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers NSAIDs for Dysmenorrhea Product Type
3.8 Tier 1, Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Players in Global Market
3.8.1 List of Global Tier 1 NSAIDs for Dysmenorrhea Companies
3.8.2 List of Global Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global NSAIDs for Dysmenorrhea Market Size Markets, 2021 & 2028
4.1.2 Ibuprofen
4.1.3 Celecoxib
4.1.4 Ketoprofen
4.1.5 Others
4.2 By Type – Global NSAIDs for Dysmenorrhea Revenue & Forecasts
4.2.1 By Type – Global NSAIDs for Dysmenorrhea Revenue, 2017-2022
4.2.2 By Type – Global NSAIDs for Dysmenorrhea Revenue, 2023-2028
4.2.3 By Type – Global NSAIDs for Dysmenorrhea Revenue Market Share, 2017-2028
4.3 By Type – Global NSAIDs for Dysmenorrhea Sales & Forecasts
4.3.1 By Type – Global NSAIDs for Dysmenorrhea Sales, 2017-2022
4.3.2 By Type – Global NSAIDs for Dysmenorrhea Sales, 2023-2028
4.3.3 By Type – Global NSAIDs for Dysmenorrhea Sales Market Share, 2017-2028
4.4 By Type – Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global NSAIDs for Dysmenorrhea Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Other
5.2 By Application – Global NSAIDs for Dysmenorrhea Revenue & Forecasts
5.2.1 By Application – Global NSAIDs for Dysmenorrhea Revenue, 2017-2022
5.2.2 By Application – Global NSAIDs for Dysmenorrhea Revenue, 2023-2028
5.2.3 By Application – Global NSAIDs for Dysmenorrhea Revenue Market Share, 2017-2028
5.3 By Application – Global NSAIDs for Dysmenorrhea Sales & Forecasts
5.3.1 By Application – Global NSAIDs for Dysmenorrhea Sales, 2017-2022
5.3.2 By Application – Global NSAIDs for Dysmenorrhea Sales, 2023-2028
5.3.3 By Application – Global NSAIDs for Dysmenorrhea Sales Market Share, 2017-2028
5.4 By Application – Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global NSAIDs for Dysmenorrhea Market Size, 2021 & 2028
6.2 By Region – Global NSAIDs for Dysmenorrhea Revenue & Forecasts
6.2.1 By Region – Global NSAIDs for Dysmenorrhea Revenue, 2017-2022
6.2.2 By Region – Global NSAIDs for Dysmenorrhea Revenue, 2023-2028
6.2.3 By Region – Global NSAIDs for Dysmenorrhea Revenue Market Share, 2017-2028
6.3 By Region – Global NSAIDs for Dysmenorrhea Sales & Forecasts
6.3.1 By Region – Global NSAIDs for Dysmenorrhea Sales, 2017-2022
6.3.2 By Region – Global NSAIDs for Dysmenorrhea Sales, 2023-2028
6.3.3 By Region – Global NSAIDs for Dysmenorrhea Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America NSAIDs for Dysmenorrhea Revenue, 2017-2028
6.4.2 By Country – North America NSAIDs for Dysmenorrhea Sales, 2017-2028
6.4.3 US NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.4.4 Canada NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.4.5 Mexico NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe NSAIDs for Dysmenorrhea Revenue, 2017-2028
6.5.2 By Country – Europe NSAIDs for Dysmenorrhea Sales, 2017-2028
6.5.3 Germany NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5.4 France NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5.5 U.K. NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5.6 Italy NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5.7 Russia NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5.8 Nordic Countries NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.5.9 Benelux NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia NSAIDs for Dysmenorrhea Revenue, 2017-2028
6.6.2 By Region – Asia NSAIDs for Dysmenorrhea Sales, 2017-2028
6.6.3 China NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.6.4 Japan NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.6.5 South Korea NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.6.6 Southeast Asia NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.6.7 India NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America NSAIDs for Dysmenorrhea Revenue, 2017-2028
6.7.2 By Country – South America NSAIDs for Dysmenorrhea Sales, 2017-2028
6.7.3 Brazil NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.7.4 Argentina NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa NSAIDs for Dysmenorrhea Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa NSAIDs for Dysmenorrhea Sales, 2017-2028
6.8.3 Turkey NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.8.4 Israel NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.8.5 Saudi Arabia NSAIDs for Dysmenorrhea Market Size, 2017-2028
6.8.6 UAE NSAIDs for Dysmenorrhea Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 IOLCP
7.1.1 IOLCP Corporate Summary
7.1.2 IOLCP Business Overview
7.1.3 IOLCP NSAIDs for Dysmenorrhea Major Product Offerings
7.1.4 IOLCP NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.1.5 IOLCP Key News
7.2 Granules Biocause
7.2.1 Granules Biocause Corporate Summary
7.2.2 Granules Biocause Business Overview
7.2.3 Granules Biocause NSAIDs for Dysmenorrhea Major Product Offerings
7.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.2.5 Granules Biocause Key News
7.3 Strides Shasun
7.3.1 Strides Shasun Corporate Summary
7.3.2 Strides Shasun Business Overview
7.3.3 Strides Shasun NSAIDs for Dysmenorrhea Major Product Offerings
7.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.3.5 Strides Shasun Key News
7.4 BASF
7.4.1 BASF Corporate Summary
7.4.2 BASF Business Overview
7.4.3 BASF NSAIDs for Dysmenorrhea Major Product Offerings
7.4.4 BASF NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.4.5 BASF Key News
7.5 SI Group
7.5.1 SI Group Corporate Summary
7.5.2 SI Group Business Overview
7.5.3 SI Group NSAIDs for Dysmenorrhea Major Product Offerings
7.5.4 SI Group NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.5.5 SI Group Key News
7.6 Hisoar
7.6.1 Hisoar Corporate Summary
7.6.2 Hisoar Business Overview
7.6.3 Hisoar NSAIDs for Dysmenorrhea Major Product Offerings
7.6.4 Hisoar NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.6.5 Hisoar Key News
7.7 Pfizer Inc
7.7.1 Pfizer Inc Corporate Summary
7.7.2 Pfizer Inc Business Overview
7.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Major Product Offerings
7.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Inc Key News
7.8 Teva
7.8.1 Teva Corporate Summary
7.8.2 Teva Business Overview
7.8.3 Teva NSAIDs for Dysmenorrhea Major Product Offerings
7.8.4 Teva NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.8.5 Teva Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan NSAIDs for Dysmenorrhea Major Product Offerings
7.9.4 Mylan NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.9.5 Mylan Key News
7.10 Apotex
7.10.1 Apotex Corporate Summary
7.10.2 Apotex Business Overview
7.10.3 Apotex NSAIDs for Dysmenorrhea Major Product Offerings
7.10.4 Apotex NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.10.5 Apotex Key News
7.11 Lupin
7.11.1 Lupin Corporate Summary
7.11.2 Lupin NSAIDs for Dysmenorrhea Business Overview
7.11.3 Lupin NSAIDs for Dysmenorrhea Major Product Offerings
7.11.4 Lupin NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.11.5 Lupin Key News
7.12 SANOFI-Aventis
7.12.1 SANOFI-Aventis Corporate Summary
7.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Business Overview
7.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Major Product Offerings
7.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.12.5 SANOFI-Aventis Key News
7.13 Boehringer-Ingelheim
7.13.1 Boehringer-Ingelheim Corporate Summary
7.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Business Overview
7.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Major Product Offerings
7.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.13.5 Boehringer-Ingelheim Key News
7.14 BEC Chemicals
7.14.1 BEC Chemicals Corporate Summary
7.14.2 BEC Chemicals Business Overview
7.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Major Product Offerings
7.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.14.5 BEC Chemicals Key News
7.15 Shandong Xinhua Pharmaceutical
7.15.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.15.2 Shandong Xinhua Pharmaceutical Business Overview
7.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.15.5 Shandong Xinhua Pharmaceutical Key News
7.16 Hengrui Medicine
7.16.1 Hengrui Medicine Corporate Summary
7.16.2 Hengrui Medicine Business Overview
7.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Major Product Offerings
7.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.16.5 Hengrui Medicine Key News
7.17 Hubei Biocause Heilen Pharmaceutical
7.17.1 Hubei Biocause Heilen Pharmaceutical Corporate Summary
7.17.2 Hubei Biocause Heilen Pharmaceutical Business Overview
7.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.17.5 Hubei Biocause Heilen Pharmaceutical Key News
7.18 Zibo Xinhua-PERRIGO Pharmaceutical
7.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Corporate Summary
7.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Business Overview
7.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Key News
7.19 Zhejiang Jiuzhou
7.19.1 Zhejiang Jiuzhou Corporate Summary
7.19.2 Zhejiang Jiuzhou Business Overview
7.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Major Product Offerings
7.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.19.5 Zhejiang Jiuzhou Key News
7.20 Hubei Xunda
7.20.1 Hubei Xunda Corporate Summary
7.20.2 Hubei Xunda Business Overview
7.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Major Product Offerings
7.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales and Revenue in Global (2017-2022)
7.20.5 Hubei Xunda Key News
8 Global NSAIDs for Dysmenorrhea Production Capacity, Analysis
8.1 Global NSAIDs for Dysmenorrhea Production Capacity, 2017-2028
8.2 NSAIDs for Dysmenorrhea Production Capacity of Key Manufacturers in Global Market
8.3 Global NSAIDs for Dysmenorrhea Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NSAIDs for Dysmenorrhea Supply Chain Analysis
10.1 NSAIDs for Dysmenorrhea Industry Value Chain
10.2 NSAIDs for Dysmenorrhea Upstream Market
10.3 NSAIDs for Dysmenorrhea Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 NSAIDs for Dysmenorrhea Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer